Background And Purpose: Only a few case reports and small series of intralabyrinthine schwannomas (ILSs) have been reported. The purpose of this study was to assess prevalence, MR characteristics, location, clinical management, and growth potential/patterns of ILSs in the largest series reported.
Materials And Methods: Lesion localization, MR characteristics, lesion growth, and clinical management were reviewed in 52 patients diagnosed with an ILS between February 1991 and August 2007 in 2 referral centers. The number of ILSs and vestibulocochlear schwannomas in the cerebellopontine angle/internal auditory canal was compared to assess the prevalence.
Results: ILSs most frequently originate intracochlearly, are hyperintense on unenhanced T1-weighted images, enhance strongly after gadolinium administration, and are sharply circumscribed and hypointense on thin heavily T2-weighted 3D images. The scala tympani is more frequently or more extensively involved than the scala vestibuli. Follow-up MR imaging, available in 27 patients, showed growth in 59% of subjects. Growth was seen from the scala tympani into the scala vestibuli and from the scala vestibuli to the saccule and vice versa. Twelve lesions were resected, and the diagnosis of ILS histopathologically confirmed.
Conclusion: ILSs can account for up to 10% of all vestibulocochlear schwannomas in centers specializing in temporal bone imaging, grow in more than 50%, and are most frequently found intracochlearly, often anteriorly between the basal and second turn. Cochlear ILSs most often originate in the scala tympani and only later grow into the scala vestibuli. Growth can occur from the cochlea into the vestibule or vice versa through the anatomic open connection between the perilymphatic spaces in the scala vestibuli and around the saccule.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128566 | PMC |
http://dx.doi.org/10.3174/ajnr.A1026 | DOI Listing |
Laryngoscope
December 2024
Department of Otolaryngology, University of Colorado School of Medicine, Aurora, Colorado, U.S.A.
Eur Arch Otorhinolaryngol
November 2024
Department of Otorhinolaryngology, All India Institute of Medical Sciences, Jodhpur, India.
Purpose: While the scala tympani (ST) is usually the preferred site for electrode insertion in cochlear implantation, anatomical variations and cochlear ossification may require scala vestibuli (SV) insertion. This systematic review evaluates the feasibility, techniques, and clinical outcomes of SV insertions compared to ST insertions, focusing on their impact on auditory performance.
Methods: A systematic review was conducted using PRISMA guidelines.
Front Neurol
October 2024
Department of Otorhinolaryngology, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.
Introduction: Although numerous studies suggest that cochlear implantation (CI) generally alleviates the overall burden of tinnitus, certain patients experience tinnitus exacerbation following CI. The exact cause of this exacerbation is still uncertain. This prospective study aimed to investigate whether cochlear trauma, resulting from scalar dislocation of the electrode array, affected postoperative tinnitus intensity, tinnitus burden, and speech perception.
View Article and Find Full Text PDFAcad Radiol
November 2024
Department of Mechanical Engineering, Columbia University, New York, NY; Columbia University Vagelos College of Physicians and Surgeons, New York, NY; Department of Otolaryngology - Head and Neck Surgery, Columbia University, New York, NY.
Rationale And Objectives: The potential of contrast-enhanced MRI for diagnosing endolymphatic hydrops is limited by long wait times following intravenous (IV) or intratympanic (IT) delivery, high contrast dosages, and inconsistent signal intensity enhancements. This study investigates microneedle-mediated intracochlear (IC) gadodiamide injection for consistent and efficient contrast delivery with minimal contrast dosage.
Materials And Methods: A 100 µm diameter microneedle with 35 µm lumen was used to inject 1 µL of diluted gadodiamide (17.
Eur Arch Otorhinolaryngol
November 2024
ENT Institute and Department of Otolaryngology, Eye and ENT Hospital, Fudan University, Shanghai, 20031, China.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!